サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1259959

アレルギー免疫療法の世界市場：市場規模、シェア、成長分析、治療タイプ別（皮下免疫療法、舌下免疫療法）、アレルギータイプ別、流通チャネル別－業界予測（2022年～2028年）

Global Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment Type(Subcutaneous Immunotherapy, Sublingual Immunotherapy ), By Allergy Type, By Distribution Channel - Industry Forecast 2022-2028
出版日: | 発行: SkyQuest | ページ情報: 英文 165 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アレルギー免疫療法の世界市場：市場規模、シェア、成長分析、治療タイプ別（皮下免疫療法、舌下免疫療法）、アレルギータイプ別、流通チャネル別－業界予測（2022年～2028年）
出版日: 2022年11月06日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のアレルギー免疫療法の市場規模は、2021年の25億米ドルから、2028年には62億米ドルになると予測されており、2022年から2028年までの予測期間中のCAGRは9.2%となっています。工業化と人口の拡大、医療と医療の進歩、新しい免疫治療薬の導入は、市場の成長を促進しています。

当レポートでは、世界のアレルギー免疫療法市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

エグゼクティブサマリー

親市場分析

市場概要

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • SWOT分析

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標

新型コロナウイルスの影響

  • イントロダクション
  • 経済シナリオ評価への影響
  • 修正された市場規模
  • COVID-19が主要セグメントに与える影響
  • COVID-19戦略：企業別

市場力学と展望

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • SWOT分析
  • ポーター分析
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力
  • 将来の混乱に関するSkyquestの特別な洞察
  • 政治的影響
  • 経済的影響
  • 社会的影響
  • 技術的影響
  • 環境的影響
  • 法的影響

世界のアレルギー免疫療法市場：治療タイプ別

  • 市場セグメント
  • 皮下免疫療法
  • 舌下免疫療法
  • 口腔アレルギー免疫療法

世界のアレルギー免疫療法市場：アレルギータイプ別

  • 市場セグメント
  • アレルギー性鼻炎
  • 喘息
  • 食物アレルギー
  • 薬剤アレルギー

世界のアレルギー免疫療法市場：流通チャネル別

  • 市場セグメント
  • 病院薬局
  • 小売薬局
  • ドラッグストア
  • オンライン薬局

市場規模：地域別

  • 北米
  • 米国
  • カナダ
  • 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • ブラジル
  • その他の南米
  • 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

主な企業プロファイル

  • 競合情勢
  • 対象となる企業の総数
  • 主要企業の市場ポジショニング
  • 主要企業の市場シェア
  • ALK Abello（英国）
  • Allergy Therapeutics（英国）
  • Circassia（英国）
  • DBV Technologies（英国）
  • HAL Allergy Group（英国）
  • Merck KGaA Allergopharma（英国）
  • Stallergenes Greer（英国）
  • Allergopharma（ドイツ）
  • Aimmune Therapeutics（米国）
  • Leti Pharma（スペイン）
  • Jubilant HollisterStier（米国）
目次
Product Code: SQSG35I2019

Global allergy immunotherapy market was valued to be USD 2.5 billion in 2021, and it is anticipated to reach USD 6.2 billion by 2028 at a CAGR of 9.2% over the forecast period (2022-2028).

According to the World Allergy Organization, 10-30% of the global population is currently affected by various types of allergies. Allergy occurs when the immune system of the body becomes abnormally sensitive to certain substances, such as a specific meal, pollen, fur, or dust. Food, dust, pollen, latex, medicines, and other allergens are examples of allergies. During allergy immunotherapy, the body is exposed to little levels of allergens in order to produce antibodies against them. Immunotherapy involves low-dose exposure to certain allergens on a frequent basis to help the body acclimatise to their presence, resulting in effective and rapid allergy treatment.

The expansion of industrialization and population, advancements in healthcare and medicine, and the introduction of new immunotherapeutic drugs are the key factors driving the global market for allergy immunotherapy. Recent regulatory approvals, such as those for oral dissolvable tablets, are being expanded in order to raise the worldwide allergy immunotherapy market share.

Top-down and bottom-up approaches were used to estimate and validate the size of global allergy immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Allergy Immunotherapy Market is segmented based on treatment type, allergy type, distribution channel and region. Based on the Treatment Type, it is categorized into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Oral Allergy Immunotherapy. Based on Allergy Type, it is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Based on the Distribution Channel, it is categorized into Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies. Based on region, it is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.

Drivers

Increasing allergy cases to help the allergy immunotherapy market grow: The increased prevalence of various allergies, as well as the development of novel sublingual immunotherapies in emerging countries, are the primary drivers of allergy immunotherapy market expansion. According to the American College of Allergy, Asthma, and Immunology, allergies are the sixth most frequent chronic ailment in the United States, costing more than USD 18 billion each year and affecting more than 50 million individuals. Food allergies are growing more widespread in both children and adults all around the world. As a result, the increased burden of allergic diseases is expected to boost demand for novel immunotherapies.

Restraints

Allergy immunotherapy, the most recent technology on the market, necessitates monthly maintenance. The cost of normal maintenance is relatively high due to the specific demand for professional workers in the process. As a result of this, the system's operational costs will climb. This is the primary cause or factor that is expected to severely impede the global allergy immunotherapy market. Furthermore, there is a need to increase awareness of this microgrid management system among many organizations, since this factor's ignorance of new technological developments may prove to be a barrier to the market's expansion for these systems.

Market Trends

High-resolution study of rare cells in local tissues has enabled the development of accurate and dependable biomarkers for allergy immunotherapy monitoring.

Aside from immunoglobulin and T-cell receptor transcript repertoires, genome-wide epigenetic changes provide a source of potential biomarkers for allergy immunotherapy monitoring.

Rare, antigen-specific immune cells can be counted and immuno-phenotyped using modern multiparameter flow and mass cytometry to track allergy immunotherapy.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Allergy Immunotherapy Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
  • Exhibit: Data Table on Global Global Allergy Immunotherapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
  • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Global Allergy Immunotherapy Market by Treatment Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Subcutaneous Immunotherapy (SCIT)
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Sublingual Immunotherapy (SLIT)
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Oral Allergy Immunotherapy
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Allergy Immunotherapy Market by Allergy Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Allergic Rhinitis
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asthma
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Food Allergy
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Drug Allergy
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Allergy Immunotherapy Market by Distribution Channel
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Hospital Pharmacies
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Retail Pharmacies
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Drug Stores
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Online Pharmacies
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
  • Total number of companies covered
  • Exhibit: companies covered in the report, 2021
  • Top companies market positioning
  • Exhibit: company positioning matrix, 2021
  • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2021(%)
  • ALK Abello (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Allergy Therapeutics (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Circassia (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • DBV Technologies (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • HAL Allergy Group (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Merck KGaA Allergopharma (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Stallergenes Greer (UK)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Allergopharma (Germany)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Aimmune Therapeutics (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Leti Pharma (Spain)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Jubilant HollisterStier (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments